XML 53 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Beginning balance at Dec. 31, 2017 $ 12,445,778 $ 1,114 $ 47,423,915 $ (34,972,787) $ (6,464)
Beginning balance, shares at Dec. 31, 2017   11,138,859     808
Common stock issued upon vesting of restricted stock units (63,149) $ 3 (63,152)    
Common stock issued upon vesting of restricted stock units, Shares   31,152      
Common stock issued for the exercise of warrants $ 3,550,490 $ 120 3,550,370    
Common stock issued for the exercise of warrants, shares   1,203,556      
Restricted stock vested   $ 3 (3)    
Restricted stock vested, shares 17,570 32,540      
Stock-based compensation $ 336,355   336,355    
Net loss (2,345,402)     (2,345,402)  
Ending balance at Mar. 31, 2018 13,924,072 $ 1,240 51,247,485 (37,318,189) $ (6,464)
Ending balance, shares at Mar. 31, 2018   12,406,107     808
Beginning balance at Dec. 31, 2017 12,445,778 $ 1,114 47,423,915 (34,972,787) $ (6,464)
Beginning balance, shares at Dec. 31, 2017   11,138,859     808
Net loss (7,624,785)        
Ending balance at Sep. 30, 2018 8,948,935 $ 1,243 51,551,728 (42,597,572) $ (6,464)
Ending balance, shares at Sep. 30, 2018   12,435,223     808
Beginning balance at Mar. 31, 2018 13,924,072 $ 1,240 51,247,485 (37,318,189) $ (6,464)
Beginning balance, shares at Mar. 31, 2018   12,406,107     808
Common stock issued upon vesting of restricted stock units (5,041) $ (1) (5,040)    
Common stock issued upon vesting of restricted stock units, Shares   3,934      
Exercise of stock options 2   2    
Exercise of stock options, shares   1,172      
Common stock issued for the exercise of warrants $ 5,901 $ 1 5,900    
Common stock issued for the exercise of warrants, shares   2,000      
Restricted stock vested   $ 1 (1)    
Restricted stock vested, shares 1,692 937      
Stock-based compensation $ 155,725   155,725    
Net loss (2,629,561)     (2,629,561)  
Ending balance at Jun. 30, 2018 11,451,098 $ 1,241 51,404,071 (39,947,750) $ (6,464)
Ending balance, shares at Jun. 30, 2018   12,414,150     808
Common stock issued upon vesting of restricted stock units $ (3,222) $ 1 (3,223)    
Common stock issued upon vesting of restricted stock units, Shares   3,971      
Restricted stock vested   $ 1 (1)    
Restricted stock vested, shares 1,653 17,102      
Stock-based compensation $ 150,881   150,881    
Net loss (2,649,822)     (2,649,822)  
Ending balance at Sep. 30, 2018 8,948,935 $ 1,243 51,551,728 (42,597,572) $ (6,464)
Ending balance, shares at Sep. 30, 2018   12,435,223     808
Beginning balance at Dec. 31, 2018 6,425,885 $ 1,245 51,720,630 (45,289,526) $ (6,464)
Beginning balance, shares at Dec. 31, 2018   12,449,379     808
Cumulative impact of ASC 606 (123,447)     (123,447)  
Proceeds of public offering, net offering costs of $710,572 5,603,829 $ 454 5,603,375    
Proceeds from offering costs, shares   4,542,500      
Common stock issued upon vesting of restricted stock units (72,115) $ 10 (72,125)    
Common stock issued upon vesting of restricted stock units, Shares   95,001      
Restricted stock vested $ 1 $ 1      
Restricted stock vested, shares 45,459 10,436      
Warrants issued as offering costs and recorded as a derivative liability $ (196,236)   (196,236)    
Stock-based compensation 396,325   396,325    
Net loss (2,598,060)     (2,598,060)  
Ending balance at Mar. 31, 2019 9,436,182 $ 1,710 57,451,969 (48,011,033) $ (6,464)
Ending balance, shares at Mar. 31, 2019   17,097,316     808
Beginning balance at Dec. 31, 2018 $ 6,425,885 $ 1,245 51,720,630 (45,289,526) $ (6,464)
Beginning balance, shares at Dec. 31, 2018   12,449,379     808
Exercise of stock options, shares 9,928        
Net loss $ (7,951,505)        
Ending balance at Sep. 30, 2019 4,418,525 $ 1,716 57,787,751 (53,364,478) $ (6,464)
Ending balance, shares at Sep. 30, 2019   17,188,929     808
Beginning balance at Mar. 31, 2019 9,436,182 $ 1,710 57,451,969 (48,011,033) $ (6,464)
Beginning balance, shares at Mar. 31, 2019   17,097,316     808
Common stock issued upon vesting of restricted stock units (6,356) $ 1 (6,357)    
Common stock issued upon vesting of restricted stock units, Shares   22,344      
Exercise of stock options 15 $ 1 14    
Exercise of stock options, shares   8,854      
Restricted stock vested $ (72) $ 1 (73)    
Restricted stock vested, shares 7,032 10,369      
Stock-based compensation $ 197,028   197,028    
Net loss (2,565,327)     (2,565,327)  
Ending balance at Jun. 30, 2019 7,061,470 $ 1,713 57,642,581 (50,576,360) $ (6,464)
Ending balance, shares at Jun. 30, 2019   17,138,883     808
Common stock issued upon vesting of restricted stock units (1,779) $ 3 (1,782)    
Common stock issued upon vesting of restricted stock units, Shares   41,837      
Exercise of stock options $ 1   1    
Exercise of stock options, shares   1,074      
Restricted stock vested, shares 3,015 7,135      
Stock-based compensation $ 146,951   146,951    
Net loss (2,788,118)     (2,788,118)  
Ending balance at Sep. 30, 2019 $ 4,418,525 $ 1,716 $ 57,787,751 $ (53,364,478) $ (6,464)
Ending balance, shares at Sep. 30, 2019   17,188,929     808